Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D6BY8P
|
|||
| Drug Name |
LYT-100
|
|||
| Synonyms |
Deupirfenidone; LYT-100; Deupirfenidone [USAN]; 1093951-85-9; 1QC36BHI6S; SD-560; UNII-1QC36BHI6S; LYT100; 2(1H)-Pyridinone, 5-(methyl-d3)-1-phenyl-; WHO 12460; 1-Phenyl-5-(trideuteriomethyl)-1,2-dihydropyridin-2-one; Pirfenidone-D3; deupirfenidone [INN]; SCHEMBL4059454; DEUPIRFENIDONE [WHO-DD]; CHEMBL5095176; GTPL12890; GLXC-26820; HY-B0673S1; AT18410; 1-phenyl-5-(trideuteriomethyl)pyridin-2-one; 5-(methyl-d3)-1-phenylpyridin-2(1H)-one; CS-0641188
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Idiopathic pulmonary fibrosis [ICD-11: CB03.4; ICD-10: J84.1; ICD-9: 516.3] | Phase 2 | [1] | |
| Company |
PureTech Health
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H11NO
|
|||
| Canonical SMILES |
CC1=CN(C(=O)C=C1)C2=CC=CC=C2
|
|||
| InChI |
InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3/i1D3
|
|||
| InChIKey |
ISWRGOKTTBVCFA-FIBGUPNXSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05321420) A Randomized Double-blind, Four-Arm Active and Placebo-controlled Dose-Finding Trial to Evaluate the Efficacy, Tolerability, Safety and Dose Response of LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.